Horizon Discovery appoints Dr Susan Galbraith and Susan Searle as Non-Executive Directors
Dr Galbraith is Senior Vice President and Head of Oncology Innovative Medicines at AstraZeneca, and Susan Searle is co-founder and ex-CEO of Imperial Innovations Group. Both join Horizon with immediate effect.
Share
What job are you looking for?
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
